Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$1.26 - $1.79 $539 - $766
-428 Reduced 1.68%
25,000 $42,000
Q3 2023

Nov 06, 2023

BUY
$1.61 - $2.54 $8,739 - $13,787
5,428 Added 27.14%
25,428 $46,000
Q2 2023

Jul 24, 2023

BUY
$1.14 - $1.95 $5,699 - $9,750
5,000 Added 33.33%
20,000 $37,000
Q1 2023

Apr 20, 2023

BUY
$1.2 - $2.19 $18,000 - $32,850
15,000 New
15,000 $19,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Guidance Point Advisors, LLC Portfolio

Follow Guidance Point Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guidance Point Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guidance Point Advisors, LLC with notifications on news.